- Report
- April 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2023
- 85 Pages
Europe
From €1445EUR$1,500USD£1,242GBP
- Report
- April 2023
- 156 Pages
Global
€4815EUR$5,000USD£4,141GBP
- Report
- April 2023
- 114 Pages
Global
€3371EUR$3,500USD£2,899GBP
- Report
- April 2023
- 109 Pages
Global
€3371EUR$3,500USD£2,899GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- February 2020
- 207 Pages
Global
From €5171EUR$5,370USD£4,448GBP
Ipratropium is a medication used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both oral and inhaled forms, and is often used in combination with other medications to treat respiratory conditions. Ipratropium is also used to treat acute exacerbations of COPD, and is sometimes used to treat acute asthma attacks.
Ipratropium is a generic drug, meaning it is available from multiple manufacturers. Some of the companies that produce and market ipratropium include GlaxoSmithKline, Boehringer Ingelheim, Teva Pharmaceuticals, and Mylan. Show Less Read more
